Board certified by the American Board of Obstetrics and Gynecology, Keith Reisler, MD, has practiced medicine for over 30 years. Specializing in women’s health, Dr. Keith Reisler of Plano, TX, completed his Obstetrics and Gynecology residency training at the University of Texas Southwestern Medical School-Parkland Hospital, and is currently a private practitioner. He is trained in a minimally invasive procedure called hysteroscopy.
A hysteroscopy is a surgical procedure without an incision that allows a clinician to examine the interior of a patient’s uterus. With the use of glycine or normal saline, the uterus is filled and a lighted instrument called a hysteroscope is inserted into the uterus via the vagina and cervix. With minimal invasion, the procedure allows for a surgeon or gynecologist to view and perform medical treatments inside the uterus.
A hysteroscopy may be used to treat abnormal vaginal bleeding via surgical removal of damaged tissue or cauterization with an electric current or laser. Additionally, the procedure allows for a clinician to determine the cause of severe blood loss due to uterine fibroids. Another advantage of a hysteroscopy is the ability for a gynecologist to administer treatment involving medications with significant side effects based on a conclusive diagnosis.
Done on an outpatient basis, a hysteroscopy takes up to 45 minutes and requires either spinal or general anesthesia. In preparation for the procedure, patients are requested to fast and abstain from ingesting any solid food or liquid drinks for up to eight hours before the exam.
Dr Keith Reisler
Having received his medical degree from State University of New York, Downstate College of Medicine, Dr. Keith Reisler of Plano, TX, has practiced healthcare for over 30 years. Specializing in women’s health, Keith Reisler, MD, is board certified by the American Board of Obstetrics and Gynecology and currently a private practitioner. He is trained in a minimally invasive procedure to remove uterine fibroids with the use of a power morcellator.
Recent findings by the Journal of the American Medical Association – Oncology reports that when a small power tool called a morcellator is used to remove fibroids in the uterus, the likelihood of causing the spread of hidden cancerous tumors inside the abdomen is low. Although reassuring, the device remains under restricted use. In fact Dr. Keith Reisler was interviewed by the Wall Street Journal regarding this subject in an article published April, 2014. At that time Dr Reisler cautioned against the use of this instrument until more studies were available.
The power morcellator uses a rotating blade, allowing a surgeon to break apart uterine fibroids or the uterus itself during a hysterectomy. After the tissue has been morcellated, the remains may be removed via tiny incisions.
While the Food and Drug Administration (FDA) cautioned clinicians not to use the power morcellator in removing uterine fibroids on most females due to the risk of having undiagnosed cancerous uterine tumors, the FDA states some younger females may still be adequate candidates for use with the device. Chief of gynecologic oncology, Dr. Jason Wright at Columbia University examined over 42,000 cases of females in the United States between 2012 and 2016 who had uterine fibroids removed. Of that, only three females developed uterine cancer from more than 3,200 power morcellator procedures. Dr Keith Reisler still cautions against the use of this instrument in most patients since there is also concern about the spread of endometriosis and fibroid tumors throughout the abdominal cavity with the use of this instrument.